Dr. Neha Patel is known for her research in type 1 diabetes, specifically technologies. Before coming to Penn State in 2017, she was involved in the initial development and clinical trials of the artificial pancreas while at Yale. She personally knows the difficulties and obstacles of managing this chronic disorder and has come to realize that research provides a path by which optimization of care can be achieved. Based on her experiences, she wishes to commit herself to becoming a physician-scientist seeking to improve diabetes care, focused on the application of technologies. One of her prior clinical trials focused on mitigating hypoglycemia during exercise on a closed-loop system, a topic on which she has presented internationally. She also has studied adjunctive therapies in type 1 diabetes, specifically sodium-glucose cotransporter-2 inhibitors. Her current study looks at the application of continuous glucose monitors in newborns with hypoglycemia. 

Dr. Patel is the principal investigator at Penn State for the Type 1 Diabetes Exchange. She has worked on various trials including TrialNet (Pathway to Prevention study - a multi-center research study dedicated to identify type 1 diabetes antibodies in people with high genetic risk) and the surveillance of COVID-19 in patients with type 1 diabetes. 

Dr. Neha Patel is active in training medical students, residents and fellows. She gives several lectures annually and is involved in bedside teaching. She also participates in the clinical didactics in the medical school curriculum at Penn State College of Medicine. 

Dr. Neha Patel's clinical interests stem from a desire to provide exceptional care for patients and to be a part of ground-breaking research in type 1 diabetes. She has expertise in a broad range of clinical and research endeavors in the field and finds the greatest joy in her interactions with children and families.

Having been personally diagnosed with type 1 diabetes at the age of 7, Dr. Patel has the personal experience to relate to patients and families, and to better serve them through providing compassionate care. She enjoys building a foundation with each family and providing personalized care, as each patient brings unique problems in all areas of pediatric endocrinology and diabetes.

She treats several disorders, including but not limited to thyroid, growth, puberty, hypopituitarism, adrenal gland excess and insufficiency and congenital disorders, and is director of the children's diabetes clinic at Penn State Children's Hospital/Penn State Health Milton S. Hershey Medical Center.

Board-certified in pediatric endocrinology, American Board of Pediatrics, 2017

Board-certified in pediatrics, American Board of Pediatrics, 2014

Member, Pediatric Endocrine Society (member, Drugs and Therapeutics Committee and Diabetes Special Interest Group)